CPHI 2026上海 | 诚邀您莅临我司展位，解锁“源”创工艺，共话全球供应链新机遇！

尊敬的业界同仁：

全球制药原料行业盛会CPHI即将于上海启幕。值此之际，诚挚邀请您出席我司在展会期间举办的 “W1A32”专场活动，共同解锁“源”创工艺。我们将围绕行业痛点、全球供应链趋势与合作机遇，展开面对面的深度交流。

公司核心产品线：

公司目前拥有甲硝唑、苯酰甲硝唑、替硝唑、地美硝唑、2-甲基-5-硝基咪唑、乙二醛、乙醛酸、2-甲基咪唑、1-甲基咪唑、咪唑、2,4,5-三氨基-6-羟基嘧啶硫酸盐、鸟嘌呤、阿昔洛韦、六氟磷酸锂、六氟磷酸钠等20余种现售产品。

产业优势与市场地位：

公司建立了较完善的医药产业链，实现了硝基咪唑类抗菌药物及抗疱疹病毒药物从起始物料、关键中间体到原料药、直至制剂的完整产品路线覆盖，已成为全球硝基咪唑类抗菌原料药及中间体、抗疱疹病毒原料药及中间体、青霉素类抗菌药物中间体的主要供应商之一，核心产品市占率行业领先。

此外，公司还生产锂电池电解液的关键材料——六氟磷酸锂，是国内最早实现工业化批量生产六氟磷酸锂的企业，并已成为比亚迪等行业领先企业的合格供应商。

本次CPHI，我们期待与您：

?探讨硝基咪唑类、抗疱疹病毒类产品的长期稳定供应方案。

?交流六氟磷酸锂/钠在新能源领域的延伸合作可能。

?分享从中间体到原料药的CDMO协同机会。

展位信息：

展位号：W1A32

地点：上海市浦东新区龙阳路2345号(W1馆）

我们已备好前沿干货与务实诚意，期待与您实现“源”分对接，携手共赢！

Dear colleagues in the industry:

The global pharmaceutical raw materials industry event CPHI is set to commence in Shanghai. On this occasion, we sincerely invite you to attend our dedicated "W1A32" session during the exhibition, where we will jointly explore innovative manufacturing processes rooted in fundamental principles. Our discussions will focus on industry challenges, global supply chain trends, and collaborative opportunities through in-person, in-depth exchanges.

The company's core product line:

The company currently offers more than 20 products, including metronidazole, metronidazole benzoate, tinidazole, dimetridazole, 2-methyl-5-nitroimidazole, glyoxal, glyoxylic acid, 2-methylimidazole, 1-methylimidazole, imidazole, 2,4,5 -triamino -6-hydroxypyrimidine sulfate, guanine, acyclovir, lithium hexafluorophosphate, and sodium hexafluorophosphate.

Industrial Advantages and Market Position:

The company has established a comprehensive pharmaceutical industry chain, achieving full coverage of the product development pathway for nitroimidazole antibacterial drugs and antiviral herpes drugs—from starting materials and key intermediates to active pharmaceutical ingredients (APIs) and final formulations. It has become one of the global leading suppliers of nitroimidazole antibacterial APIs and intermediates, antiviral herpes API and intermediate products, as well as penicillin-based antibacterial drug intermediates, with its core products holding a market share that leads the industry.

Furthermore, the company produces lithium hexafluorophosphate—the key material for lithium battery electrolytes—and is the first domestic enterprise to achieve industrial-scale mass production of this compound. It has also become a primary qualified supplier for industry leaders such as BYD.

For this CPHI event, we look forward to working together with you:

?Explore long-term supply strategies for nitroimidazole-based and antiviral herpes products.

?Discussion on potential extended cooperation between lithium hexafluorophosphate and sodium hexafluorophosphate in the new energy sector

?Explore CDMO collaboration opportunities from intermediates to active pharmaceutical ingredients.

Booth Information:

· Date:16th-18th of June,2026

· Booth Number: W1A32

· Location: No.2345 Longyang Road, Pudong New Area, Shanghai (Hall W1)

We have prepared cutting-edge insights and genuine commitment, looking forward to collaborating with you to achieve alignment at the core level and achieve mutual success！